Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Jul;46(1):51–57. doi: 10.1038/bjc.1982.164

Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia.

S E Heckford, S A Eccles, T J Powles, P Alexander
PMCID: PMC2011070  PMID: 7104197

Abstract

Animals bearing metastatic fibrosarcomas were treated with cyclophosphamide (CY) alone or in combination with flurbiprofen (FP), an inhibitor of prostaglandin synthesis. FP did not affect local growth of fibrosarcomas, and the incidence of distant metastases after resection of the "primary" implants was comparable in treated and control groups. Treatment with CY retarded growth of the fibrosarcomas and reduced the proportion of animals which succumbed to metastases, but this was not altered significantly by additional treatment with FP. FP did not affect the survival of rats bearing a lymphoid leukaemia. The lifespan of animals treated with CY was increased significantly, but the concomitant administration of FP did not enhance this effect.

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins D., Ibbotson K. J., Hillier K., Hunt N. H., Hammonds J. C., Martin T. J. Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer. 1977 Nov;36(5):601–607. doi: 10.1038/bjc.1977.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett A., Carter R. L., Stamford I. F., Tanner N. S. Prostaglandin-like material extracted from squamous carcinomas of the head and neck. Br J Cancer. 1980 Feb;41(2):204–208. doi: 10.1038/bjc.1980.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett A., Houghton J., Leaper D. J., Stamford I. F. Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins. 1979 Feb;17(2):179–191. doi: 10.1016/0090-6980(79)90037-6. [DOI] [PubMed] [Google Scholar]
  4. Bennett A., McDonald A. M., Simpson J. S., Stamford I. F. Breast cancer, prostaglandins, and bone metastases. Lancet. 1975 May 31;1(7918):1218–1220. doi: 10.1016/s0140-6736(75)92197-2. [DOI] [PubMed] [Google Scholar]
  5. Berstock D. A., Houghton J., Bennett A. Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis. Adv Prostaglandin Thromboxane Res. 1980;6:567–569. [PubMed] [Google Scholar]
  6. Grinwich K. D., Plescia O. J. Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis. Prostaglandins. 1977;14(6):1175–1182. doi: 10.1016/0090-6980(77)90294-5. [DOI] [PubMed] [Google Scholar]
  7. Hial V., Horakova Z., Shaff F. E., Beaven M. A. Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. Eur J Pharmacol. 1976 Jun;37(2):367–376. doi: 10.1016/0014-2999(76)90044-3. [DOI] [PubMed] [Google Scholar]
  8. Jaffe B. M., Parker C. W., Philpott G. W. Immunochemical measurement of prostaglandin or prostaglandin-like activity from normal and neoplastic cultured tissue. Surg Forum. 1971;22:90–92. [PubMed] [Google Scholar]
  9. Jaffe B. M. Prostaglandins and cancer: an update. Prostaglandins. 1974 Jun 25;6(6):453–461. doi: 10.1016/s0090-6980(74)80055-9. [DOI] [PubMed] [Google Scholar]
  10. Levine L., Hinkle P. M., Voelkel E. F., Tashjian A. H., Jr Prostaglandin production by mouse fibrosarcoma cells in culture: inhibition by indomethacin and aspirin. Biochem Biophys Res Commun. 1972 May 26;47(4):888–896. doi: 10.1016/0006-291x(72)90576-1. [DOI] [PubMed] [Google Scholar]
  11. Lynch N. R., Castes M., Astoin M., Salomon J. C. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer. 1978 Oct;38(4):503–512. doi: 10.1038/bjc.1978.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mantovani A. Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity. Int J Cancer. 1978 Dec;22(6):741–746. doi: 10.1002/ijc.2910220617. [DOI] [PubMed] [Google Scholar]
  13. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Plescia O. J., Smith A. H., Grinwich K. Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci U S A. 1975 May;72(5):1848–1851. doi: 10.1073/pnas.72.5.1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Powles T. J., Alexander P., Millar J. L. Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of P.G. synthesis. Biochem Pharmacol. 1978 May 1;27(9):1389–1392. doi: 10.1016/0006-2952(78)90127-2. [DOI] [PubMed] [Google Scholar]
  16. Powles T. J., Dowsett M., Easty G. C., Easty D. M., Neville A. M. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. Lancet. 1976 Mar 20;1(7960):608–610. doi: 10.1016/s0140-6736(76)90416-5. [DOI] [PubMed] [Google Scholar]
  17. Strausser H. R., Humes J. L. Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in balb/c mice. Int J Cancer. 1975 May 15;15(5):724–730. doi: 10.1002/ijc.2910150503. [DOI] [PubMed] [Google Scholar]
  18. Tan W. C., Privett O. S., Goldyne M. E. Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 1974 Dec;34(12):3229–3231. [PubMed] [Google Scholar]
  19. Tashjian A. H., Jr, Voelkel E. F., Goldhaber P., Levine L. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. Prostaglandins. 1973 Apr;3(4):515–524. doi: 10.1016/0090-6980(73)90161-5. [DOI] [PubMed] [Google Scholar]
  20. Trevisani A., Ferretti E., Capuzzo A., Tomasi V. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumour growth by non-steroidal anti-inflammatory drugs. Br J Cancer. 1980 Mar;41(3):341–347. doi: 10.1038/bjc.1980.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Whittle B. J., Higgs G. A., Eakins K. E., Moncada S., Vane J. R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature. 1980 Mar 20;284(5753):271–273. doi: 10.1038/284271a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES